2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Neoplasms
5
Melanoma
4
Carcinoma, Renal Cell
4
Lymphoma, Follicular
3
Lymphoma
3
Sarcoma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Carcinoma, Hepatocellular
2
Zollinger-Ellison Syndrome
1
Virus Diseases
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Philadelphia Chromosome
1
Multiple Myeloma
1
Meningeal Carcinomatosis
1
Lymphoproliferative Disorders
1
Lymphomatoid Granulomatosis
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Kidney Neoplasms
1
Influenza, Human
1
Hepatitis B, Chronic
1
Hepatitis B
1
Heartburn
1
Gastrointestinal Cancer Metastatic
1
Epstein-Barr Virus Infections
1
Interventions
Cyclophosphamide
64
Peripheral Blood Stem Cell Transplantation
58
fludarabine phosphate
55
Busulfan
44
Tacrolimus
39
Methotrexate
38
Cytarabine
37
Filgrastim
34
Mycophenolic Acid
33
Cyclosporine
33
Antilymphocyte Serum
32
Whole-Body Irradiation
28
Radiotherapy
25
Methylprednisolone
22
Imatinib Mesylate
22
Etoposide
22
Melphalan
18
Cord Blood Stem Cell Transplantation
18
Flow Cytometry
14
Thiotepa
12
Dasatinib
12
Therapeutics
11
sargramostim
10
merphos
10
fludarabine
10
Sirolimus
10
Granulocyte Colony-Stimulating Factor
10
nilotinib
9
Prednisone
9
Decitabine
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Blast Crisis
×
Interferons
×
Clear all
NCT00763763
2011-10-05
AFR07
Assistance Publique - Hôpitaux de Paris
Phase 2
Completed
55 enrolled